INTRODUCTION
Patient-specific induced pluripotent stem cells (iPSCs) are considered a valuable tool to model various types of diseases, in particular based on genetic defects. Moreover, it is presumed that iPSC technology, in combination with targeted gene editing technologies, will open a new era in drug development and testing (Ebert et al., 2012; Merkert and Martin, 2018) . The development of high-throughput (HT) assays for drug screening, however, is considerably exacerbated by the need for much larger cell numbers, robust differentiation protocols, and the requirement for automated and reliable readout systems. It is therefore not surprising that as yet not many successful iPSC-based screens have been conducted in drug development in a true HT format (Shi et al., 2017) .
Despite these apparent challenges, such screens have important advantages compared with primary cells and immortalized cell lines. These include (1) the possibility of collecting patient-specific source cells, (2) the unlimited potential for propagation, (3) the option to generate different cell lineages from one patient-derived cell source, (4) the possibility for targeted genome engineering on a clonal level, (5) the existence of a cell lineage-specific normal intracellular signal cascade, regulation, and proteostasis environment, and (6) the possibility to integrate the influence of genetic modifiers that play an important role in the clinical manifestation of a disease. Overall, it is expected that iPSC-based phenotypic screening approaches will result in higher success rates of compounds than from conventional target-based screens (Vincent et al., 2015) .
In the case of cystic fibrosis (CF), recent HT screens have identified modulators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), a chloride channel expressed in secretory epithelia (Galietta, 2013) . These can be classified as CFTR potentiators, which restore the channel activity by enhancing gating, and correctors, which are able to rescue trafficking of specific mutants to the cell surface in vitro, including the most common CFTR mutant (p.Phe508del). By applying immortalized cell lines, the CFTR potentiator VX-770 and the CFTR correctors VX-661 and VX-809 were identified. VX-770 was reported to increase chloride secretion about 10-fold in primary human bronchial epithelial (HBE) cells heterozygous for the gating mutation p.Gly551Asp (Van Goor et al., 2009), whereby VX-809 was able to enhance chloride secretion in HBE cells from homozygous p.Phe508del patients to 14% of wild-type activity in vitro (Van Goor et al., 2011) . Results from clinical trials of VX-809 on homozygous patients, however, were modest at best (Clancy et al., 2012) . Even with the combination of the potentiator VX-770 and the corrector VX-809 for homozygous p.Phe508del, CF patients showed an improvement in lung function to a relatively low extent (Graeber et al., 2018; Wainwright et al., 2015) . The new triple combination of CFTR modulators (VX-661, VX-659, VX-770) so far promises considerably more effect (Davies et al., 2018) but needs further evaluation.
It is therefore clear that previous in vitro models for correctors are poor predictors of clinical efficacy, although the most promising compounds were even validated on primary human epithelial cells. This underlines the need for the identification of novel compounds with a screening system that closely recapitulates the in vivo situation and the complexity of CF disease more accurately and reliable. With patient-derived iPSCs, a suitable source of expandable CF patient-derived cells is now available that can be genetically engineered to establish appropriate reporter cell lines and can be differentiated toward different CFTR-expressing derivatives of the most affected organs, including lung (Huang et al., 2015) , bile duct (Dianat et al., 2014) , and intestinal epithelia (McCracken et al., 2011) .
Here, we show that intestinal epithelia differentiated from genetically engineered CF patient-derived iPSCs and their isogenic control cells after seamless correction of the p.Phe508del mutation can be utilized in an HT drug screening approach. Screening of $42,500 chemical compounds resulted in the identification of a number of validated primary hits that showed rescue of CFTR function to a different extent, underlining that even complex functional organotypic screens based on disease-specific iPSC derivatives can be conducted in a true HT format. Further comprehensive analyses are now required to investigate the degree of CFTR rescue in primary airway cells to identify binding sites and to elucidate mechanisms of action of the individual compounds.
RESULTS

Requirement for an Isogeneic Control Cell Line with Seamless Correction of the p.Phe508del Mutation
Isogenic iPSC control lines with seamless correction of the respective disease-specific mutation are generally considered as ultimate control in iPSC-based disease modeling. Gene editing of iPSCs and the subsequent clonal selection procedure, however, may not only lead to introduction of new mutations but also to the selection of cell clones with (epi)genetic aberrations that show altered culture characteristics and differentiation behavior. In order to confirm the similarity of the CFTR p.Phe508del line MHHi002-A and its seamless corrected counterpart MHHi002-A-1 (Merkert et al., 2017) to be used in our screen, we have compared the global gene expression of both cell lines before and after intestinal differentiation ( Figure 1 ). Principal component analysis (PCA) revealed close clustering of the CFTR p.Phe508del line (donor 2 derived) with its isogenic gene-corrected counterpart, but more divergence from two unrelated human iPSC lines (donor 1 and donor 6 derived), either in the undifferentiated state ( Figure 1A ) or after intestinal differentiation (Figure 1B) . This indicates, that despite gene editing and the single-cell cloning procedure, the seamless corrected subclone is still much more similar to the parental cell line than other unrelated iPSC lines, all generated in the same laboratory. This was confirmed by a more detailed comparison of differentially expressed genes (DEGs) between the divergence from the two other hiPSC lines (donor 1 and donor 6), both in the undifferentiated state on day 0 (A) and on day 15 of directed differentiation (B). n = 3 independent differentiations for each line. For further analyses, also see Figure S1 . (C) Schematic illustration of the targeting strategy applied for TALEN-mediated integration of the neomycin-2A-dTomato nuc reporter cassette. The CFTR gene is targeted at exon 1 in-frame with the ATG start codon. Gray arrows indicate primers used to confirm targeted integration of the reporter construct. NeoR, neomycin resistance gene; T2A, self-cleaving peptide sequence; dTomato nuc , dimeric variant of dsRed fluorescent protein coupled to nuclear membrane location signal; frt, flippase recognition target site; PGK, phosphoglycerate kinase promoter; HygroR, hygromycin resistance gene. (D) Schematic illustration of the protocol for iPSC differentiation toward CFTR dTomato -expressing intestinal epithelial cells. iPSCs cultured as monolayer were induced to DE via the STEMdiff Definitive Endoderm Kit. Following the application of dorsomorphin and IWP-2, the intestinal specification was promoted using BMP4, CHIR, and FGF10. (E) Representative fluorescence microscopy showing emerging dTomato nuc -positive cells during the time course of directed differentiation of CFTR KO/Tom cells toward epithelial cells. BF, bright field. Scale bars represent 100 mm. (F) Quantification of dTomato nuc -positive cells on day 15 of directed differentiation of four CFTR-dTomato nuc reporter iPSC lines toward intestinal epithelial cells (mean ± SEM from three independent differentiations). (G) Fold change of dTomato nuc and CFTR expression during the time course of directed differentiation of four CFTR-dTomato nuc reporter iPSC lines (mean ± SEM from three independent differentiations). The knockout allele in the CFTR KO/Tom line was generated via deletion of the Kozak sequence, which will result in mRNA transcription but not in CFTR protein translation (see also Figure S1E ). applied cell lines, which resulted in higher numbers of DEGs for the comparison of unrelated cell lines, either genetically engineered (donor 6 derived) or not further engineered (donor 1), in contrast to the comparison of the mutation-corrected subclone and its parental cell line (Figures S1A and S1B). Table 1 .
Generation of Human
Differentiation of CFTR dTomato Reporter iPSC Lines
Considering the very complex, costly, and timeconsuming culture protocols for differentiation into airway cells, we decided to develop an HT assay based on CFTR-expressing intestinal epithelia, which can be generated using a much shorter and less costly protocol. For the generation of CFTR-expressing intestinal epithelia, a stepwise differentiation protocol via definitive endoderm (DE) and posterior endoderm was developed ( Figure 1D , for details see Supplemental Information). All cell lines were capable of generating DE as shown by CXCR4/C-KIT and CXCR4/EPCAM co-staining on day 4 of differentiation (Figures S1F and S1G), although with slightly less efficiency in the case of the CFTR p.Phe508del/Tom and CFTR corr/Tom cell lines. CFTRdTomato nuc -positive cells emerged around day 8 during the time course of differentiation. After 15 days, the cultures showed distinct CFTR-dTomato nuc -expressing cells with clear fluorescence localization restricted to the cell nuclei ( Figure 1E ). Microscopic quantification of the dTomato nuc signal on day 15 of differentiation resulted in an average of 58% and 45% positive cells for the CFTR KO/Tom and CFTR wt/Tom cell clones and 17% and 6%
for the CFTR p.Phe508del/Tom and CFTR corr/Tom clone, respectively ( Figure 1F ). dTomato nuc mRNA expression started to increase from day 8 of differentiation, which reflected the kinetics of the CFTR mRNA expression ( Figure 1G ) and the appearance of the red fluorescence in the differentiation cultures.
Detailed Characterization of the Intestinal Epithelial Cell Population
Microarray expression analysis of the resulting cell populations on day 15 of differentiation and tissue controls (intestine and liver) were conducted. PCA revealed a clear separation of differentiated (d15) hiPSCs from their undifferentiated (d0) counterparts and adult liver but close clustering with adult intestine (Figure 2A ). More detailed comparative expression analyses were conducted for all genes with >2-fold elevated expression (p > 0.01) in differentiated (d15) versus undifferentiated iPSCs (d0) and in intestine versus undifferentiated (d0) iPSCs (Table S3 ). In Figure S1E ). d Neomycin-dTomato nuc reporter. e Based on MHHi002-A, which was heterozygously corrected with ssODNs (Merkert et al., 2017) .
total, 4,045 genes were significantly upregulated in the d15 differentiation samples compared with undifferentiated (d0) iPSC samples; 5,018 genes were detected with significantly elevated expression in adult intestinal tissue with its diverse cellular components compared with d0 cells (Table S3 ). Comparative analysis of both gene lists resulted in an intersection of 2,094 genes (Table S3) , which were significantly upregulated in both groups, accounting for about 51% of the upregulated genes in the differentiated cells ( Figure 2B ). Detailed analysis of the genes with elevated expression showed enrichment of GO terms connected to intestinal absorption (GO 0098865, 0030299), immunity (GO 0002446, 0043312), brush border membrane (GO 0031526), and epithelial cell differentiation (GO0030855) ( Figure S2A ) (Chen et al., 2013; Kuleshov et al., 2016) . Furthermore, differentiated cells and intestine showed a shared expression pattern indicated by the expression levels of selected individual genes involved in digestive tract development, intestinal cell differentiation/development, and genes expressed in the mature intestine (e.g., SI, VIL1, LCT, ALPI) ( Figure 2C ). Markers connected to the development such as GATA5, GATA6, CCBR, FGFR3, and EGFR were also elevated in the differentiated population, suggesting that the iPSC-derived intestinal cells did not adopt a fully mature adult phenotype. In addition, a gene list (Table S4 ) compiled of GO term lists connected to intestine development and function as well as gene lists from the human protein atlas for intestine and colon (https://www.proteinatlas.org) was used to further compare expression profiles of undifferentiated cells (d0), differentiated cells (d15), and intestine. The generated heatmap of upregulated genes underlines the intestinal-like expression pattern of the differentiated cells ( Figure 2D ). Differentiated CFTR-expressing epithelial cells were dissociated on day 15 of differentiation and seeded at high density on membrane inserts for functional analyses. When re-seeding the cells on Laminin-511-coated inserts, low cuboidal morphology and also ZO-1 expression, indicating intact tight junctions, could be observed ( Figure S2B ), which consistently (n = 3) resulted in higher transepithelial electrical resistance (TEER) than collagen I/fibronectin or Geltrex coating (data not shown). Four days after seeding, TEER reached on average 1,130 U cm 2 in CFTR corrected cells and 1,070 U cm 2 in the mutated cells ( Figure S2C ). Apical surface liquid (ASL) height measurements were performed to assess the transepithelial fluid transport capacity of the differentiated cells on the filters. While no response to Forskolin could be observed in CFTR mutated cells ( Figure S2D ), the addition of Forskolin increased the CFTR-dependent fluid transport activity in corrected cells at a rate of approximately 12 mm/h, indicating that the iPSC-derived cell population expresses all required apical and basolateral transport systems in addition to the apical chloride channel CFTR. Figure 3E ). The differentiated cells were analyzed for CFTR activity in a microscopic Cl À /I À exchange assay (Galietta et al., 2001b ) ( Figure 3F ). In the preparation of a plate reader-based HT screening with our differentiated reporter cells, we included a 24 h pre-incubation step for putative correctors in DMSO ( Figure 3F ). The whole-cell batch analysis of the HS-eYFP intensity changes revealed comparable results with the analysis of individual dTomato nuc -positive cells ( Figure S3D ). Therefore, we continued analyzing the HS-eYFP fluorescence changes as batch analyses of the entire differentiated cell population. Forskolin stimulation of CFTR wt/Tom and CFTR corr/Tom cells resulted in a significant reduction of the HS-eYFP fluorescence after the addition of iodide, which was absent in CFTR KO/Tom as well as in CFTR p.Phe508del/Tom cells ( Figure 3G , left graph). To verify the specificity of the CFTR-mediated HS-eYFP reduction, the CFTR channel was specifically inhibited via CFTR(inh)-172, a thiazolidinone-class inhibitor acting as closed-channel stabilizer. CFTR(inh)-172 has been used as a selective inhibitor to identify CFTR currents in various cell types (Ma et al., 2002a; Thiagarajah et al., 2004) . This resulted in a considerable reduction of halide transport in CFTR wt/Tom and CFTR corr/Tom cells in comparison with Forskolin stimulation only ( Figure 3G , right graph). All recorded traces were summarized via calculation of the maximal slope after iodide addition and statistically analyzed ( Figure 3H ). We obtained significant differences for CFTR activation with and without CFTR(inh)-172 treatment in differentiated CFTR wt/Tom as well as in CFTR corr/Tom cells. Furthermore, a significant difference in halide transport was detected between differentiated Figure 2 . Human iPSC-Derived Epithelial Cells Share Expression Patterns with Adult Intestine (A) PCA was conducted on undifferentiated hiPSCs (d0) (n = 11, independent biological samples), differentiated hiPSC (d15) (n = 12, independent biological samples), adult intestine (n = 3, technical replicates), and adult liver (n = 3, technical replicates). Differentiated hiPSCs (d15) cluster with adult intestine (in red) but are distinct from undifferentiated hiPSCs (d0) and adult liver (in cyan).
(legend continued on next page) S3F ).
Development and Conduction of an HT Screening Assay
In order to use our functional iPSC-based assay for HT drug screening, the iPSC-derived CFTR-expressing intestinal epithelial cells were dissociated on day 13 of differentiation and re-plated into a 384-well format using a device microplate dispenser. A seeding density of 10,000 cells/well was chosen to ensure the formation of a tight epithelial layer. We performed a primary HT screen of $42,500 compounds from the FMP compound library of the chemical biology platform (Lisurek et al., 2010 ) at a single concentration of 10 mM. The whole screening workflow ( Figure 4C ) comprising cell seeding on day 13 of differentiation, medium exchange, and compound transfer on day 14, as well as the Cl À /I À exchange assay on day 15, was performed in an automated manner. This enabled the handling of up to 26 384-well plates per differentiation batch leading to the accomplishment of the whole library after five screening rounds. The quality of the differentiated cell batches was assessed by day 4 flow cytometry analyses for DE formation and day 13 qPCR analysis for CFTR and CDX2 expression (Figures S4B and S4C) . We calculated the slopes from the FLIPR TM kinetic curves using R software and evaluated the performance of our assay based on the range between positive (corrected cells) and negative controls (mutated cells). We assessed the assay quality using in-house software, applying Z 0 factor and Z score calculations for each screening plate. Generated graphics enabled visualization of the statistical value distribution over plate and edge effects ( Figure 4D ). The Z 0 factor, which represents the assay response window, was 0.55, supporting the feasibility and reproducibility of the screening ( Figure 4E ). Potential hits were identified by determination of the relative activity of the compounds in comparison with the mutated (value 0) and the genetically corrected cells (value 1). After fixation and staining of cell nuclei, automated image analysis for determination of cell numbers/well was applied to detect the potential toxicity of individual compounds (Figure 4F) . After primary screening, we identified 86 hit compounds with a relative activity >0.38 ( Figure 5A ). For these compounds, a validation run was performed, whereby 11 concentrations from 20 mM to 0.02 mM were tested in duplicates. All 86 tested compounds were ranked according to their relative activity compared with the hit cutoff of 0.38 as well as by visual confirmation of the kinetic curves. This resulted in preselection of 21 verified hits ( Figure 5B ). Among those, seven compounds reached the relative (B) A Venn diagram was created from gene lists containing genes with R2-fold elevated expression (p > 0.01) in d15 differentiation cultures compared with d0 cultures (yellow, 4,045 genes) and in adult intestine compared with d0 cultures (green, 5,018 genes). The intersection of both gene lists contains 2,094 genes.
(C) Relative expression levels of selected individual genes connected to intestinal epithelial cell differentiation/development, digestive tract development, biliary/hepatic cells (and also intestinal development), as well as brush border enzymes/cytoskeleton in undifferentiated iPSCs (d0; n = 11), differentiated iPSCs (d15; n = 12), and adult intestine (n = 3).
(D) A heatmap of upregulated genes in differentiated cells (d15) and intestine compared with undifferentiated cells (d0) was created based on a gene list compiled of GO terms connected to intestine development and function (http://www.geneontology.org/) and genes listed in the human protein atlas for intestine and colon (https://www.proteinatlas.org/), further demonstrating that differentiated cells are more similar to adult intestine than to undifferentiated cells (d0). (legend continued on next page) activity hit cutoff at a concentration of 10 mM, nine compounds at 20 mM, and five compounds were included as borderline compounds although they showed less activity at both concentrations ( Figures 5C, S5A , and S5B). Among those 21, we selected our ten most promising compounds ( Figures S5C and S5D ) as the top candidates for prioritized testing for chemical structure clustering as well as further investigation in secondary assays.
DISCUSSION
To capture the pathophysiology of a disease, the application of organotypic iPSC-based models that incorporate the genomic background in connection with the corresponding clinical phenotypes already in the earliest in vitro assays may result in better clinical translation (Engle and Vincent, 2014; Swinney and Anthony, 2011) . Since genetic modifiers play an important role in the clinical manifestation of CF (Tümmler and Stanke, 2014), we did not consider unrelated wild-type iPSCs as proper control for the patient-derived CFTR p.Phe508del/Tom cells, but applied isogenic corrected cells generated by targeted gene editing for the HT screen. While it has been shown that the genetic background contributes to the CF phenotype, it has not been investigated in detail whether mutations and epigenetic differences unintentionally acquired during targeted gene editing or selected during the single-cell cloning procedure may also cause functional alterations relevant for disease modeling and drug screening. We therefore considered it important to explore the degree of similarity between the two cell lines used in the HT screen, the CFTR p.Phe508del/Tom iPSC line and the disease corrected counterpart CFTR corr/Tom , including their differentiated progeny.
Remarkably, our microarray analysis underlines the general significance of isogenic control cell lines. Despite various steps of genetic engineering and single-cell cloning, both undifferentiated and differentiated derivatives of the seamless corrected subclone (applied as positive control in our HT screen) cluster much closer to their mutated parental counterparts in terms of DEGs than two unrelated CFTR wild-type iPSC lines with different genetic background. Since robust and reliable differentiation protocols are a basic requirement for iPSC-based HT screens, we sought to eliminate sources of interference wherever possible. In order to achieve a robust intestinal differentiation, we always started from iPSC monolayers cultured under defined conditions. Moreover, a commercial endoderm differentiation kit, which in our hands yielded the most reproducible results, and, as far as possible, small molecules instead of recombinant proteins were applied to further increase the reliability of the differentiation protocol. During subsequent differentiation, intestinal marker genes, including CDX2, SI, and VIL1, were significantly upregulated. In addition, we also found upregulation of genes frequently considered as hepatic and biliary genes (e.g., AFP, HNF4a, KRT19, KRT7). This might be prevented by addition of FGF4, which was shown to suppress the formation of hepatic gene expression at the hindgut stage (Tamminen et al., 2015) . The hepatic and biliary markers detected, however, are also known to be expressed on intestinal cells during development (Cirillo et al., 1995; Stammberger and Baczako, 1999; Tsai et al., 2017; Verzi et al., 2013) . Since on the other hand some marker genes for mature secretory epithelia cells (e.g., MUC2, CHGA) are not expressed in our intestinal cell population, we conclude that our intestinal cell population does not show a fully mature adult phenotype.
The use of iPSC lines that express a dTomato nuc fluorochrome under control of one allele of the CFTR locus enabled visualization of CFTR-expressing cells during intestinal differentiation. Because of the lack of reliable anti CFTR antibodies for the detection of relatively low physiological protein expression levels (Kalin et al., 1999; Mendes et al., 2004) , we refrained from co-staining of our dTomato nuc -expressing cells with any CFTR antibodies. Nevertheless, since the kinetics of CFTR-dTomato nuc mRNA expression correspond to the appearance of dTomato nuc -positive cells during differentiation, and because the CFTR mRNA expression detected could be functionally confirmed in our HS-eYFP assay, there is no reason to doubt the specificity of the dTomato nuc reporter, which is placed under control of the endogenous CFTR locus.
It is noteworthy that both reporter lines derived from MHHi006-A reproducibly showed a substantially higher proportion of CFTR-dTomato nuc -expressing cells than the MHHi002-A derived lines. In addition, we observed negative (mutated cells in green) and positive (genetically corrected cells in blue) controls. Three data points were determined as outliers and subsequently removed from the positive replicate data. Gray solid lines represent the mean (m), dotted lines represent respective 3-fold SD (s). (F) Cell distribution of a representative 384-well screening plate monitored by automated microscopy of Hoechst 33342 stained nuclei. Counted nuclei analysis was used for exclusion of toxic compounds. (C) Scatterplot graph of EC 50 validation at 10 mM as the mean (n = 2 independent plates). Depicted are all 86 potential hits from the primary screen. Compounds confirming relative activity above hit cutoff at 10 mM are depicted in red, at 20 mM in dark red, and borderline compounds in orange. differences in terms of the formation of CFTR-dTomato nucexpressing cells also between the genetically engineered subclones of MHHi006-A, and between subclones of MHHi002-A. Already the efficiency of endoderm differentiation was line dependent with both MHHi006-A lines reproducibly yielding about 90% pure DE under the given conditions. These differences were accompanied by clear differences in the proliferation rates of the four lines during culture expansion and further differentiation. The differing proliferation rates of the four lines very likely explain at least in part the different amounts of CFTR-positive cells, and may be adjustable by individualized timing of the differentiation protocol for each line. The observed different proliferation and differentiation characteristics underline the impact of the genetic background and clonal variations.
In addition to the availability of functional iPSC derivatives that allow mimicking the disease in a dish, another critical requirement for iPSC-based HT screens is the potential for automation. For measurement of CFTR function in vitro, in particular the use of a halide-sensitive eYFP reporter, is straightforward and can be automated due to its simplicity and sensitivity (Ma et al., 2002b) . The respective HS-eYFP (Galietta et al., 2001a) , however, has so far been applied only for functional measurement of CFTR transgenes overexpressed in immortalized cell lines (Ma et al., 2002b; Park et al., 2016) but not to analyze more moderate levels of endogenous CFTR in primary epithelia or stem cell derivatives. Here, we demonstrate that the halide-sensitive eYFP-H148Q-I152L-F46L variant facilitates measurement of endogenous CFTR function in iPSC-derived epithelia. While a normal CFTR response was detected in CFTR wt/Tom cells, no significant decrease in the HS-eYFP fluorescence could be observed in the CFTR KO/Tom cells.
Remarkably, the seamless correction of the CFTR p.Phe508del mutation in the CFTR corr/Tom cell line perfectly restored CFTR function to wild-type levels in our microscope-based HS-eYFP assay as well as in the plate reader setting. Furthermore, the CFTR function detected in CFTR wt/Tom and CFTR corr/Tom cells could be blocked by CFTR(inh)-172. Similar to other studies in which CFTR overexpressing cell lines were applied (Caci et al., 2008; Fischer et al., 2010; Ma et al., 2002a) , we did not observe full inhibition of the CFTR channel activity, which might be an effect of the interior negative membrane potential of epithelial cells reducing the CFTR(inh)-172 potency. Interestingly, we observed comparable levels of CFTR function in intestinal epithelia derived from the MHHi006-A CFTR wild type and the genetically corrected MHHi002-A-1 iPSC line, although the proportion of CFTRdTomato nuc -expressing cells in the respective differentiation cultures was quite divergent (6% versus 45%; see also discussion above , 2005) , which might be useful for drug combination strategies and still bear the potential for improvement after structural optimization. Finally, we adapted our assay to the 384-well HT plate reader format and conducted an HT screen for potential CFTR modulators in a fully automated screening environment. Intestinal epithelia cells instead of airway cells were chosen for the HT assay because of the shorter, more reproducible, and less cost-intensive differentiation protocol. Further validation of compounds and testing of compound combinations can be performed in secondary assays on different disease-relevant cell types derived from the same CF reporter iPSC lines, as well as on primary airway cells or intestinal organoids from other patients.
In conclusion, our study underlines the feasibility of HT screens based on iPSC-derived epithelia for identification of potentiators and correctors of mutated CFTR. Clonal genome engineering approaches can be utilized in iPSCs to integrate fluorescence reporters that enable visualization of CFTR expression during differentiation and facilitate automated measurement of CFTR function at an HT scale. In contrast to p.Phe508del CFTR overexpressing immortalized cell lines, iPSC-based screens incorporate the influence of the proteostasis environment on CF disease and the efficacy of correctors. Our approach, based on cells with a more physiological array of proteins involved in protein folding, quality control, degradation, and trafficking, and with more physiological levels of CFTR expression, will favor the development of correctors with novel mechanisms of action, more relevant to the therapeutic goal in vivo. Forthcoming HT screens will show whether such iPSC-based organotypic assays are better predictors of clinical compound efficacy than conventional HT screens.
EXPERIMENTAL PROCEDURES
For detailed description see Supplemental Experimental Procedures.
Cell Culture
We used the HSC_F1285_T-iPS2 (Hartung et al., 2013) cell line, registered (https://hpscreg.eu/) as MHHi006-A, the CF iPSC line MHHi002-A and its corrected counterpart MHHi002-A-1 (Merkert et al., 2017) , all generated in our research group. Unless indicated otherwise, all pluripotent stem cell lines were cultured under standard conditions essentially as previously described (Merkert et al., 2014) .
TALEN-Based Targeted Gene Editing
For the integration of the reporter constructs, iPSCs grown as monolayer cultures were dissociated and transfected with the respective TALEN expression and donor plasmids. Cells were seeded either onto hygromycin-resistant feeder cells for CFTR targeting or on Geltrex coated culture vessels for AAVS1 targeting. For the generation of CFTR dTomato reporter cell lines, the hygromycin-based clone selection was initiated 72 h post transfection for 4 days. Arising colonies were transferred manually onto irradiated feeder cells to generate single-cell clones. For the generation of AAVS1 eYFP reporter cell lines, eYFP pos cells were sorted via fluorescence-activated cell sorting and plated in limiting dilution. Upcoming colonies were picked manually and expanded clonally.
iPSC Differentiation
In a stepwise differentiation protocol, iPSCs from monolayers in essential 8 (E8) medium were first differentiated to DE via a STEMdiff Definitive Endoderm Kit (TeSR-E8 Optimized) from STEMCELL Technologies. DE cells on day 4 of differentiation were cultured for 2 days in the presence of dorsomorphin and ROCK inhibitor. Thereafter, cells were treated for 1 day with IWP-2. From day 7 until day 15, cells were cultured in the presence of CHIR99021, BMP4, and FGF10.
Microscope-Based Chloride/Iodide Exchange Assay
Cells on day 13 of differentiation and undifferentiated cells serving as controls were seeded on glass-bottom dishes ( Figure 3F ). On day 15, individual cell or batch analysis of eYFP fluorescence intensity after addition of sodium iodide was performed microscopically at 37 C. Cells were washed once with PBS and incubated with Forskolin, Forskolin + CFTR(inh)-172, or respective DMSO control, respectively. eYFP fluorescence was recorded continuously for 120 s with one picture per second. Thirty seconds after the start of recording, iodide-rich PBS was added and the fluorescence intensity was measured for another 90 s. Negative values reflect a decrease of eYFP fluorescence intensity.
Plate Reader-Based Chloride/Iodide Exchange Assay Cells were dissociated on day 13 of differentiation and seeded on black 384-well plates. The next day, the compounds were applied in differentiation medium and incubated for 24 h at 28 C. To start the assay, the cells were washed three times with PBS and incubated for 45-50 min at room temperature with 20 mM Forskolin + 1 mM VX-770. The eYFP fluorescence intensity was analyzed for 120 s with 1 read/s in an FLIPR Tetra system. After 30 s, the 2.75-fold volume of iodide-rich PBS was automatically added, and the change in eYFP fluorescence intensity further monitored. Afterward, the cells were fixed with paraformaldehyde and stained with Hoechst 33342 for automated cell counting.
Statistics
Statistical analyses were performed with GraphPad Prism6 and the results are presented as means ± SEM, unless otherwise noted. Significance of two groups was analyzed using the unpaired t test. Statistical significance was assigned as follows: *p % 0.05; **p % 0.01; ***p % 0.001; ****p % 0.0001.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/ 10.1016/j.stemcr.2019.04.014.
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Supplemental Experimental Procedures Plasmid Vectors
For the CFTR targeting donor vector a neomycin resistance cassette (neoR) and a dTomato-fluorescent protein coupled to a nuclear membrane localization signal (dTomato nuc ) were fused in frame with a T2A protease sequence ( Figure 2C ). The resulting expression cassette neoR-2A-dTomato nuc was cloned in front of a FRT flanked PGK driven hygromycin resistance cassette. Afterwards, this construct was cloned between two arms of ~ 500 bp CFTR locus homology sequences, in frame with the CFTR exon 1 start codon. Monoalleleic introduction of this transgeneic cassette should lead to simultaneous expression of dTomato nuc from one allele and CFTR from the other one. The eYFP-H148Q-I152L-F46L transgene variant was placed under control of a cytomegalovirus early enhancer element fused with the chicken beta-actin (CAG) promoter for ubiquitous expression, flanked by two arms of homology for the AAVS1 safe harbour locus on chromosome 19 to generate the donor targeting vector ( Figure  3C ). TALEN pairs to target the exon 1 of the human CFTR locus (2011-L: TCGCCTCTGGAAAAGGCCA; 2012-R: AACTTTTTTTCAGGTGAGA) were generated via the golden gate assembly method, by modular cloning of custom TALE-type DNA binding domains . The TALEN pair for AAVS1 targeting was previously published (Merkert et al., 2014) . TALENs are based on the NΔ134/C+17 architecture (Mussolino et al., 2011) , contain wild-type FokI nuclease domains and the expression is driven by the CMV promoter.
Targeted Gene Editing
For the integration of the reporter constructs, iPSCs grown as monolayer culture in MEF-conditioned iPSC medium (Burridge et al., 2011) on Geltrex ® were dissociated with StemPro ® Accutase ® (both supplied by Thermo Fisher Scientific). Cells were transfected using the Neon ® Transfection System (Thermo Fisher Scientific) according to the following protocol: 1 x 10 6 cells were resuspended in 105 µl Neon buffer with 15 µg donor plasmid and the respective TALENs (5 µg of each plasmid), electroporated with two pulses at 1000 V for 20 ms and seeded in medium supplemented with 10 μM ROCK inhibitor (Institute for Technical Chemistry, Leibniz University, Hannover) either onto hygromycin resistant feeder cells for CFTR targeting or on Geltrex 
Analyses of gene-edited iPSC clones: PCR-analysis and Southern blotting
Genomic DNA of targeted cells was isolated with QIAamp DNA Blood Mini Kit (QIAGEN) according to the manufacturer's instructions. For PCR analysis 100 ng gDNA were used for amplification with GoTaq ® G2 DNA Polymerase (Promega) or Phire Green Hot Start II DNA Polymerase (Thermo Fisher Scientific). PCR primers were manufactured by Eurofins MWG Operon (Ebersberg) and dissolved in water at 100 µM. Sequences and specifications of primers are listed in Table S1 .
Intestinal Differentiation of iPSCs iPSCs cultured as monolayer in essential 8 (E8) medium (Beers et al., 2012) . In a stepwise differentiation protocol the iPSCs were first differentiated to DE via STEMdiff™ Definitive Endoderm Kit (TeSR™-E8™ Optimized) from STEMCELL Technologies according to manufactures instructions with slight adaptations for every cell line regarding cell seeding density and timing of DE differentiation. After generation of definitive endoderm, KnockOut TM DMEM with 1% L-glutamine, 1% nonessential amino acid stock, 1% penicillin/streptomycin, 5% KnockOut TM serum replacement and 0.46 mM 1-thioglycerol (Sigma-Aldrich) was used as basal medium (BM). DE cells on day 4 of differentiation were seeded at a density of 2.7 x 10 4 cells/cm 2 and cultured for 2 days in BM supplemented with 10 μM ROCK inhibitor. In addition, 3 μM dorsomorphin (Sigma-Aldrich), an inhibitor of the BMP type I receptors ALK2, 3 and 6 (Yu et al., 2008) was included to further enhance endoderm differentiation (Sherwood et al., 2011) and to inhibit formation of mesenchyme, which potentially represents an important source of endogenous growth factors, including Wnts (Tamminen et al., 2015) that might interfere with further intestinal differentiation. On day 6 of differentiation the medium was changed to BM containing 2 μM IWP-2 (Tocris Bioscience) a Wntpathway inhibitor to block potential mesoderm formation (Loh et al., 2014) .. Modified from a differentiation approach for the generation of intestinal organoids as reported by Spence et al. and Tamminen et al. (Spence et al., 2011; Tamminen et al., 2015) , we established a protocol for further differentiation into CFTR expressing epithelia. Spence et al. used WNT3A and FGF4 to induce CDX2 and hindgut development in definitive endoderm and achieved 3D organoid formation in the presence of Wnt activator R-spondin1 (Spence et al., 2011) . Subsequently, Tamminen et al. showed that even more potent CDX2 upregulation can be achieved with the Wnt-pathway activator CHIR99021. Moreover, Tamminen et al. demonstrated that FGF4 is not only dispensable for intestinal differentiation, FGF4 addition after d9 even diminished the upregulation of intestinal markers (Tamminen et al., 2015) . Other studies showed that BMP ligands, and in particular BMP4 inhibit foregut fate and promote posterior endoderm formation (De Santa Barbara et al., 2005; Stevens et al., 2017; Zorn and Wells, 2009 ). In our protocol, we combined treatment with 15 ng/ml BMP4 (R&D Systems) and 3 μM CHIR99021 (Institute for Technical Chemistry, Leibniz University, Hannover) starting on day 7, to repress the foregut fate and instead promote formation of posterior endoderm and specify the intestinal fate. In addition, 15 ng/ml FGF10 (R&D Systems) was applied to promote survival and proliferation of the generated intestinal cells (Sala et al., 2006) .
Microscope based chloride/iodide exchange assay
Cells on day 13 of differentiation were dissociated via incubation with 1 mg/ml collagenase type II (Worthington) in Hank's Balanced Salt Solution (Thermo Fisher Scientific) for 45 min at 37°C, followed by addition of StemPro ® Accutase ® for 15 min. Cells were seeded on CELLview TM glass-bottom dishes (Greiner Bio-One) at a density of 1 x 10 5 to 1.5 x 10 5 cells/cm 2 in respective differentiation medium supplemented with 10 µM ROCK inhibitor. Undifferentiated cells serving as control were plated on CELLview TM glass-bottom dishes at a density of 0.5 x 10 5 to 1.0 x 10 5 cells/cm 2 in E8 medium supplemented with 10 µM ROCK-inhibitor ( Figure 3F) . On day 15, individual cell or batch analysis of eYFP fluorescence intensity after addition of sodium iodide was performed at 37°C via Nikon Ti eclipse microscope with Andor/Yokogava Spinning Disk X1 and NIS-Elements AR software using 488 nm laser excitation with 520 nm emission and Plan Apo ʎ 40x 0.95 0.25-0.17 objective. Cells were washed once with PBS and incubated for 40-55 min at 37°C with 20 µM Forskolin, , 20 µM Forskolin + 20 µM CFTR(inh)-172 or respective DMSO control (supplied by Sigma-Aldrich and Selleck Chemicals), respectively. eYFP fluorescence was recorded continuously at 37°C for 120 s with one picture per second. 30 sec after start of recording the 2.75 fold volume of iodide-rich PBS (137 mM NaI, 2.7 mM KCl, 8.1 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 1 mM CaCl 2 and 0.5 mM MgCl 2 , pH 7.4) was added manually (≤ 2 sec) and the fluorescence intensity was measured for another 90 sec. Data were analyzed with Fiji software (ImageJ) via quantification of total eYFP fluorescence intensity of each picture with ROI Manager. Resulting traces were imported to GraphPad Prism6 and fitted via non-linear regression ("plateau followed by one phase decay") in case of functional CFTR expressing cells. Traces of homozygous p.Phe508del cells were fitted via linear regression of the first 10 sec after addition of iodide. Changes of eYFP fluorescence intensity are expressed as the maximal slope determined by calculation of the first derivative of the fitted curves. In case of homozygous p.Phe508del cells changes of eYFP fluorescence intensity are reported as slope of the linear regression. Negative values reflect a decrease of eYFP fluorescence intensity.
Plate reader based chloride/iodide exchange assay
The plate reader based Cl -/I -exchange assay was performed in cooperation with the Screening Unit of the Leibniz-Institute for Molecular Pharmacology, Berlin, Germany. Therefore, cells were dissociated on day 13 of differentiation as described above. Dissociated cells were seeded via the EL406 Washer Dispenser (BioTek Instruments) on black 384-well plates (Corning) with a density of 1.0 x 10 5 cells/well in respective differentiation medium supplemented with 10 µM ROCK inhibitor. The next day, the compounds were applied in differentiation medium and incubated for 24 hours at 28°C. For starting the assay, the cell were washed three times with PBS and incubated for 45-60 min at room temperature with 20 µM Forskolin + 1 µM VX-770. The eYFP fluorescence intensity was analyzed for 120 s with one read/second in the FLIPR Tetra system with the ScreenWorks® software (both from Molecular Devices). After 30 s the 2.75 fold volume of iodide-rich PBS was automatically added and the change in eYFP fluorescence intensity further monitored. Afterwards, the cells were fixed with PFA and stained with Hoechst 33342. The cell numbers were monitored by automated microscopy (ArrayScanTM XTI Instrument, HCS studio software, Thermo Fisher).
Random Differentiation
For random differentiation iPSCs were detached from feeder cells using 0.2% collagenase type IV, dispersed into small cell clumps and cultured in ultra-low attachment plates (Corning) in 80% Iscove's modified Dulbecco's medium, 20% fetal calf serum, 1% nonessential amino acid stock, 0.1 mM ß-mercaptoethanol and 1 mM L-glutamine. On day 7 of differentiation embryoid bodies were plated on tissue culture plates (coated with 0.1% gelatin solution) and cultured until day 16 before fixation and immunocytological staining.
TEER and ASL measurements
Dissociated iPSC-derived intestinal epithelial cells were seeded at high density (4x10 5 /cm 2 ) in differentiation medium on 6.5 mm membrane inserts (Costar Transwell) coated for 2 hrs with Laminin-511 (50 µg/ml) (BioLamina. Sundyberg). Medium was changed after 24 hrs. Four days after seeding TEER was measured using an EVOM2 Voltohmmeter and forceps Ag/AgCl electrodes (WPI, Sarasota Fl, USA).
For ASL height analysis, cells were treated at day 4 with 2 µM VX-809. Next day, ASL height measurements were performed, using a Leica SP5 confocal microscope, equipped with a GalvanoZ programmable stage. Briefly, 10 µl medium was added to the apical compartment, and 20 µl Fluorinert FC-77 (Sigma) to reduce evaporation. ASL height was measured sequentially in 12 wells, four sites per filter at 5 minute intervals, by measuring the distance between the filter and the meniscus using the 488 nm laser in reflection mode. Series of Z-scans were collected, and analyzed with an algorithm in ImageJ software. 30 minutes after starting the measurement, 1 µM EIPA, an inhibitor of the apical Na/H exchanger involved in fluid resorption in biliary epithelium was added, and at 60 minutes 3 µM Forskolin and 0.3 µM VX770 was added to activate CFTR activity.
Reverse transcription and quantitative real-time PCR Total RNA was isolated from TRIzol ® -lysed cells via NucleoSpin ® RNA II Kit (Macherey-Nagel), followed by c-DNA synthesis with RevertAid TM H Minus First Strand cDNA Synthesis Kit (Thermo Fisher Scientific) using random hexamer primers according to the manufacturer's protocol. Quantitative real-time PCR was performed with Absolute qPCR SYBR Green Mix (Thermo Fisher Scientific). Sequences and specifications of primers for real time PCR are listed in Table S1 . Expression levels of target genes were normalized to the housekeeping gene human ß-actin; to analyze relative changes in gene expression Ct method was applied.
Microarray
The Microarray utilized in this study represents a refined version of the Whole Human Genome Oligo Microarray 4x44K v2 (Design ID 026652, Agilent Technologies), called '026652QM_RCUG_HomoSapiens' (Design ID 084555) developed by the Research Core Unit Genomics (RCUG) of Hannover Medical School. Microarray design was created at Agilent's eArray portal using a 1x1M design format for mRNA expression as template. All non-control probes of design ID 026652 have been printed five times within a region comprising a total of 181560 Features (170 columns x 1068 rows). 150 to 400ng of total RNA were hybridized with Cy3-labeled cRNA synthesized with the 'Low Input Quick Amp Labeling Kit One-Color' (#5190-2305, Agilent Technologies). cRNA fragmentation, hybridization and washing steps were carried-out as recommended in the 'One-Color Microarray-Based Gene Expression Analysis Low Input Quick Amp Labeling Protocol V6.7', except that 2000 to 3000ng of labeled cRNA were used for hybridization. Slides were scanned on the Agilent Micro Array Scanner G2565CA (pixel resolution 3 µm, bit depth 20). Data extraction was performed with the 'Feature Extraction Software V10.7.3.1' by using the recommended default extraction protocol file 'GE1_107_Sep09.xml'. Data were analysed using Qlucore Omics Explorer 3.0 (Qlucore AB) for principal component analysis, heatmap and Venn diagram generation. Measurements of on-chip replicates were averaged using the geometric mean of processed intensity values of the green channel, 'gProcessedSignal' (gPS) to retrieve one resulting value per unique non-control probe. Single Features were excluded from averaging, if they i) were manually flagged, ii) were identified as Outliers by the Feature Extraction Software, iii) lie outside the interval of '1.42 x interquartile range' regarding the normalized gPS distribution of the respective on-chip replicate population, or, iv) showed a coefficient of variation of pixel intensities per Feature that exceeded 0.5. Averaged gPS values were finally normalized by quantile normalization approach. The microarray data were deposited under accession number GSE129168 in the Gene Expression Omnibus database (https://www.ncbi.nlm.nih.gov/geo/).
Immunocytology and flow cytometry
Cells were fixed for 20 min with 4% paraformaldehyde (w/v) and stained with primary antibodies (listed in Table S2 ) and appropriate secondary antibody (DyLight 549_donkey_anti-mouse_IgG or DyLight 549_donkey_anti-rabbit_IgG, both 1:200, Jackson Immunoresearch Laboratories) using standard protocols. Cells were also stained with corresponding isotype antibody as negative control. Cell nuclei were stained with DAPI (Sigma-Aldrich) and samples were analyzed using the AxioObserver A1 fluorescence microscope and Axiovision software 4.8 (Carl Zeiss). The DE associated surface marker staining with C-Kit, CXCR4, EPCAM and respective isotype controls was performed with dissociated, living cells. For this purpose, 2 x 10 5 cells were stained for 30 min on ice and were analyzed via flow cytometry using BD Accuri C6 (BD Biosciences) after two washing steps. For quantification of dTomato nuc expressing cells the differentiation cultures were fixed on day 14 or 15. In order to compensate for a fixation-related attenuation of the dTomato nuc signal, fixed cells were stained with a cross-reacting anti-mCherry antibody. DAPI staining was performed to enable counting of total nuclei. For each cell line 10 spots per differentiation were randomly chosen and photographed. The total number of DAPI nuclei versus the number of dTomato nuc positive cells was determined by applying Fiji software (ImageJ) and the percentage of dTomato nuc positive cells was calculated. For confocal IF, filters were fixed with 4% PFA. After washing, filters were blocked for 30 min in 1 % BSA, 5 % donkey serum in PBS / 0.2 % Triton-X100 (TX). The primary antibody was incubated overnight at 4°C. The next day the filters were rinsed and washed three times in PBS / 0.02 % TX followed by a 2 hr secondary antibody (AF647_donkey_anti-mouse, AF594_donkey_anti-rabbit, Thermo Scientific) incubation at room
